menu
    • menu

    Company profile for Orient Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Orient Pharma (OP), focusing on R&D and manufacturing and established on Feb 1, 2008, is the subsidiary of Orient Europharma(OEP). Located in Yunlin county in the central of Taiwan, the plant was completely constructed in 2010 Q2. The Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA in July, 2011. In addition, it received “Accreditation Certificate of Foreign Drug Manufacturer” from Japan Ministry of H...
    Orient Pharma (OP), focusing on R&D and manufacturing and established on Feb 1, 2008, is the subsidiary of Orient Europharma(OEP). Located in Yunlin county in the central of Taiwan, the plant was completely constructed in 2010 Q2. The Yunlin plant obtained the approval for PIC/S GMP from the Taiwan FDA in July, 2011. In addition, it received “Accreditation Certificate of Foreign Drug Manufacturer” from Japan Ministry of Health, Laboar, and Welfare (MHLW) in April, 2012. Furthermore, the Yunlin plant passed the cGMP site inspection by US FDA in April 2013.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Orient PharmaTaiwan Flag
    Country
    Country
    Taiwan
    Address
    Address
    2F, No. 368, Sec. 1 Fu Hsing S. Road,Taipei 106
    Telephone
    Telephone
    886-2-23257621
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.oppharma.com/index.php/eng/index
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OncoVentEnters into a License and Distribution Agreement with Orient EuroPharma
    OncoVentEnters into a License and Distribution Agreement with Orient EuroPharma

    28 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/oncovent-a-subsidiary-of-hepalink-enters-into-a-license-and-distribution-agreement-with-orient-europharma-for-the-immunotherapeutic-candidate-oregovomab-301783039.html

    PR NEWSWIRE
    28 Mar 2023
    Share Share
    Orient's Generic Ezetimibe Receives Approval in the U.S.
    Orient's Generic Ezetimibe Receives Approval in the U.S.

    13 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215693

    FDA
    13 Sep 2022
    Share Share
    Orient Pharma's Generic Pitavastatin Calcium Receives Approval In US
    Orient Pharma's Generic Pitavastatin Calcium Receives Approval In US

    03 Feb 2017

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205932

    FDA
    03 Feb 2017
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Orient Pharma and get a quotation

    Orient Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Phenylephrine Hydrochloride bulk offered by Orient Pharma

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search